Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies, including Hims & Hers and other compounding pharmacies, as similar alternatives to FDA-approved drugs. The agency said the actions are intended to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy. The agency also emphasized ongoing concerns around promotional claims and direct-to-consumer messaging, building on the The FDA is also taking steps to combat misleading direct-to-consumer advertising and marketing following warning letters that were sent in the fall of 2025, the agency said
High-performance liquid chromatography analysis of low molecular mass thiols and disulfides
If youre interested in learning whether Melanotan I is right for you, we encourage you to connect with our experienced team for a consultation.
Peptide therapy, such as combinations like Sermorelin, Ipamorelin, and CJC1295, seeks to support this process by stimulating your bodys own GH production
Complex Partial Seizures For adults and children 10 years of age or older
STYLE OF SPORT: How heavy are your clients that are taking GLP-1s
